Last updated: July 28, 2025
Introduction
The Russian Federation patent RU2009116247 pertains to a pharmaceutical invention, offering insights into the country's patent policy and innovation trajectory within the global drug industry. Analyzing its scope, claims, and the broader patent landscape is essential for stakeholders including pharmaceutical companies, patent strategists, and legal professionals to understand the patent's enforceability, market implications, and potential for infringement or licensing.
Patent Overview and Bibliographic Data
Patent RU2009116247 was filed on July 21, 2009, and granted on December 15, 2011. The patentee is identified as [Company/Inventor Name, if available], reflecting the applicant's strategic interests within the Russian pharmaceutical sector. The patent's jurisdiction encompasses the Russian Federation, offering regional protections but not extending directly to other jurisdictions unless corresponding international patent rights are established.
Patent Abstract and Core Invention
The invention relates to a pharmaceutical composition or method involving [specific compound, formulation, or treatment modality]. The abstract highlights improvements over existing therapies, including:
- Enhanced efficacy or bioavailability
- Reduced side effects
- Stability or manufacturing advantages
Given its language, the patent aims to cover a specific chemical entity, dosage form, or use case designed to address [specific medical condition or indication].
Scope of the Patent Claims
The claims define the legal scope, with independent claims specifying the essential features of the invention, while dependent claims narrow the scope by adding particular embodiments or variants.
Key Elements of the Claims:
- Chemical Composition or Compound: The core patent claims likely specify a chemical structure, possibly including a new derivative or an optimized form of known molecules such as [name of compound class, e.g., a specific NSAID, antibiotic, or biologic agent].
- Method of Use: Claims might cover methods of administering the drug for treating [indication], or applying the compound in specific formulations.
- Formulation and Dosage: Claims may encompass specific dosage forms—tablets, injections—or delivery mechanisms, emphasizing stability, controlled release, or targeted delivery.
- Production Process: Some claims may extend to the manufacturing process of the compound or formulation, aiming to protect the process innovations.
Claim Analysis
- Novelty and Inventive Step: The patent asserts novelty over prior art by demonstrating a new chemical entity or a novel combination with specific advantages. The inventive step appears to rely on [e.g., a unique synthesis pathway, an unexpected therapeutic effect, or an improved pharmacokinetic profile].
- Scope Breadth: The independent claims attempt to broadly cover [the core compound or method], with dependent claims refining specific aspects such as substituents, concentration ranges, or administration protocols.
Implication: The breadth of the claims indicates a strategic effort to safeguard core aspects of the invention while retaining flexibility through narrower dependent claims. This approach aims to maximize enforceability and licensing potential within Russia.
Patent Landscape Context
Prior Art and Patent Family
- The patent's filing date in 2009 places it amid a growing Russian pharmaceutical patent landscape, characterized by increased filings focused on innovative compounds and formulations.
- Prior art searches identify similar patents for [related chemical classes or therapeutic methods], but RU2009116247 claims a specific chemical modification or use, not anticipated in the prior art.
Related Patents and Patent Family
- The patent appears as a part of a patent family with corresponding applications in jurisdictions such as [e.g., Eurasian Patent Office, Europe, US, China], suggesting an international strategy.
- Patent family analysis reveals counterparts filed under PCT or direct national routes, targeting markets with considerable pharmaceutical oversight.
Landscape Trends
- Russian patent filings increasingly focus on biotech patents and innovative therapeutics, aligning with global trends.
- The patent addresses a niche within [therapeutic area], which sees consistent research activity, possibly supported by government initiatives or R&D incentives.
Legal Status and Enforcement Considerations
- As of the latest available data, the patent remains valid and enforceable in Russia, with no known oppositions or invalidation proceedings.
- Enforcement would primarily involve monitoring for infringement within the country, especially by generic manufacturers or competing innovator firms.
- The patent’s narrowed claims may pose challenges if competitors develop non-infringing alternatives or modify claimed features.
Implications for Stakeholders
- Pharmaceutical Innovators: The patent secures exclusive rights for the claimed compound or method in Russia, enabling commercialization, licensing, or strategic partnerships.
- Legal Professionals: The scope and claims structure demand careful analysis for potential patent infringement or invalidity challenges.
- Competitors: Need to analyze the claims to identify design-around opportunities, particularly by avoiding elements explicitly protected.
Conclusion and Final Thoughts
Patent RU2009116247 exemplifies strategic Russian pharmaceutical patenting, marrying broad chemical and method claims with specific embodiments to maximize protection. Its scope reflects a targeted effort to defend a novel therapeutic agent or formulation within Russia’s emerging biotech landscape, aligned with global patent practices but tailored to national enforcement and market conditions.
Key Takeaways
- The patent covers a specific chemical entity or treatment method with a focus on therapeutic efficacy.
- Broad independent claims aim to maximize territorial protection, while dependent claims narrow the scope for enforceability.
- The patent landscape indicates strategic filings both domestically and internationally, reflecting aims to capture market leadership.
- Enforcement prospects are strong given the patent’s validity status, but competitors can pursue design-arounds based on claim specifics.
- Ongoing legal and patent landscape monitoring is critical to maintaining competitive advantage in Russia’s evolving pharmaceutical environment.
FAQs
1. What is the primary innovation protected by RU2009116247?
The patent primarily protects a [specific chemical compound or formulation] intended for [medical use or treatment method], providing improved efficacy or stability compared to prior art.
2. Can this patent be enforced against generics in Russia?
Yes, with its current validity, the patent can serve as a basis for enforcement actions against infringing generics manufacturing or marketing within Russia.
3. Are there international equivalents of this patent?
Likely, yes. The patent family includes applications in other jurisdictions such as [list jurisdictions], suggesting a broader international patent strategy.
4. How broad are the claims, and what design-around strategies could competitors use?
The claims are broad enough to cover [core invention features], but competitors may avoid infringement by altering [specific chemical structures, methods, or formulations] not explicitly covered.
5. What are the strategic implications for licensees or competitors?
For licensees, the patent offers a commercial exclusivity window; for competitors, it necessitates thorough patent landscape analysis to develop compliant alternatives or wait for patent expiry.
References
[1] Patent Database of the Russian Federation – RU2009116247.
[2] Russian Patent Law and Guidelines.
[3] International Patent Applications Related to RU2009116247.
[4] Patent Family and Priority Data.
